Single Pluripotent Stem Cell Culture via Trypsin and Defined Medium
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for culturing human embryonic stem cells are hindered by the need for complex conditions, including xenogeneic cells and animal serum, which increase contamination risks and lead to genetic abnormalities and loss of pluripotency when passing cells as single cells.
Innovation Solution
A method involving the release of pluripotent stem cells as single cells using trypsin treatment for 2-5 minutes, followed by plating on a tissue culture substrate with an extracellular matrix component, such as MATRIGEL, to maintain pluripotency and prevent chromosomal abnormalities, allowing for expansion and differentiation into specific cell types like definitive endoderm and pancreatic endoderm cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If xenogeneic cells and animal serum are used in culture systems, then embryonic stem cells can be cultured and maintained, but the risk of viral and xeno protein contamination increases
Solution Approach 1:
The patent removes xenogeneic feeder cells and animal serum from the culture system, replacing them with a chemically defined serum-free medium containing basic fibroblast growth factor. This extraction of harmful elements eliminates the source of viral and xeno protein contamination while maintaining stem cell culture capability through alternative growth factors.
Solution Approach 2:
The culture system transitions from complex conditions requiring feeder cells and serum to a simplified defined medium with specific growth factors. The parameter change involves specifying exact concentrations of bFGF (e.g., 2-20 ng/mL) and other components, creating a controlled environment that maintains pluripotency without contamination risks.
2Productivity
If embryonic stem cells are passed as single cells, then culture expansion is facilitated, but genetic abnormalities and loss of pluripotency occur
Solution Approach 1:
The patent identifies specific cultural parameters including bFGF concentration ranges (2-20 ng/mL), pH levels (6.8-7.4), and temperature (37°C) that enable single cell passage while maintaining pluripotency. These parameter optimizations allow high productivity through single-cell expansion without the genetic abnormalities that typically occur.
Solution Approach 2:
Basic fibroblast growth factor acts as an intermediary substance that mediates between single cell state and pluripotency maintenance. The bFGF signaling pathway provides the necessary cues for single cells to remain undifferentiated and genetically stable, bridging the gap between expansion capability and pluripotency preservation.
3Reliability
If complex culture conditions with feeder cells are used, then embryonic stem cell pluripotency is maintained, but the culture system complexity increases
Solution Approach 1:
The patent extracts and removes the complex feeder cell layer requirement from the culture system. By eliminating this complex biological component and replacing it with a defined chemical medium containing bFGF and other growth factors, the system achieves pluripotency maintenance through simpler, more controllable parameters.
Solution Approach 2:
The invention replaces long-term, complex feeder cell cultures with a disposable defined medium formulation. The chemically defined medium can be prepared and stored without requiring maintenance of feeder cell lines, simplifying the overall system and reducing long-term complexity while maintaining culture quality.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method ensures high cell viability (>98%) and maintains pluripotency without chromosomal abnormalities, enabling efficient expansion and differentiation of human embryonic stem cells into desired cell types, facilitating large-scale culturing and research applications.
Implementation Method 1
releasing pluripotent stem cells as single cells from clusters of pluripotent stem cells by treatment with trypsin
Data Source
Figure 1
Figure 2
Figure 3A~3B
AI summary
The present invention relates to the field of pluripotent stem cell culture and methods facilitate pluripotent stem cell culture at industrial levels.